Discovery of T-cell Driven Subunit Vaccines from Zika Virus Genome: An Immunoinformatics Approach

Interdisciplinary Sciences – Computational Life Sciences

Volumn 9, Issue 4, 2017, Pages 468-477

  Pradhan, Dibyabhaba ^a   Yadav, Monika ^a   Verma, Rashi ^a   Khan, Noor Saba ^a   Jena, Lingaraja ^b   Jain, Arun Kumar ^a  

^a SAFDARJUNG HOSPITAL CAMPUS   (India)

^b MAHATMA GANDHI INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

IEDB; NetMHC; Subunit vaccine; T cell epitope; Zika virus

Indexed keywords

SUBUNIT VACCINE;

BIOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; PROCEDURES; T LYMPHOCYTE; VIRUS GENOME; ZIKA VIRUS;

COMPUTATIONAL BIOLOGY; GENOME, VIRAL; T-LYMPHOCYTES; VACCINES, SUBUNIT; ZIKA VIRUS;

EID: 85036653726     PISSN: 19132751     EISSN: 18671462     Source Type: Journal    
DOI: 10.1007/s12539-017-0238-3     Document Type: Article

References (57)

1. Campos GS, Bandeira AC, Sardi SI (2015) Zika Virus Outbreak, Bahia, Brazil. Emerg Infect Dis 21(10):1885–1886
2. Zanluca C, de Melo VCA, Mosimann ALP, Santos GIVD, Santos CNDD, Luz K (2015) First report of autochthonous transmission of Zika virus in Brazil. Mem Inst Oswaldo Cruz 110(4):569–572
3. (2016) Zika virus on the move. Cell 164(4):585–587
4. Musso D, Baud D (2016) Zika virus: time to move from case reports to case control. Lancet Infect Dis
5. Fauci AS, Morens DM (2016) Zika virus in the Americas—yet another arbovirus threat. N Engl J Med 374(7):601–604
6. Vogel G (2016) Emerging diseases. A race to explain Brazil’s spike in birth defects. Science 351(6269):110–111
7. (2016) Zika virus: a new global threat for 2016. Lancet Lond Engl 387(10014):96
8. WHO (2016) Zika virus and potential complications [Internet]. WHO. http://www.who.int/emergencies/zika-virus/en/
9. Freire CC de M, Iamarino A, Neto DF de L, Sall AA, Zanotto PM de A (2015) Spread of the pandemic Zika virus lineage is associated with NS1 codon usage adaptation in humans. bioRxiv 25;032839
10. Enfissi A, Codrington J, Roosblad J, Kazanji M, Rousset D (2016) Zika virus genome from the Americas. Lancet Lond Engl 387(10015):227–228
11. Zhu Z, Chan JF-W, Tee K-M, Choi GK-Y, Lau SK-P, Woo PC-Y et al (2016) Comparative genomic analysis of pre-epidemic and epidemic Zika virus strains for virological factors potentially associated with the rapidly expanding epidemic. Emerg Microbes Infect 5:e22
12. Hamel R, Dejarnac O, Wichit S, Ekchariyawat P, Neyret A, Luplertlop N et al (2015) Biology of zika virus infection in human skin cells. J Virol 89(17):8880–8896
13. (2016) Zika Virus Vaccine Research [Internet]. https://www.niaid.nih.gov/topics/Zika/ResearchApproach/Pages/vaccineResearch.aspx
14. De Groot AS (2003) How the SARS vaccine effort can learn from HIV-speeding towards the future, learning from the past. Vaccine 21(27–30):4095–4104
15. De Groot AS, Moise L, Liu R, Gutierrez AH, Terry F, Koita OA et al (2014) Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design. Hum Vaccines Immunother 10(2):256–262
16. Terry FE, Moise L, Martin RF, Torres M, Pilotte N, Williams SA et al (2015) Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases. Expert Rev Vaccines 14(1):21–35
17. Mishra S, Losikoff PT, Self AA, Terry F, Ardito MT, Tassone R et al (2014) Peptide-pulsed dendritic cells induce the hepatitis C viral epitope-specific responses of naïve human T cells. Vaccine 32(26):3285–3292
18. Oyarzun P, Kobe B (2015) Recombinant and epitope-based vaccines on the road to the market and implications for vaccine design and production. Hum Vaccines Immunother
19. De Groot AS, Sbai H, Aubin CS, McMurry J, Martin W (2002) Immuno-informatics: mining genomes for vaccine components. Immunol Cell Biol 80(3):255–269
20. Chen H-W, Hu H-M, Wu S-H, Chiang C-Y, Hsiao Y-J, Wu C-K et al (2015) The immunodominance change and protection of CD4+ T-cell responses elicited by an envelope protein domain III-based tetravalent dengue vaccine in mice. PLoS ONE 10(12):e0145717
21. Shi J, Sun J, Wu M, Hu N, Li J, Li Y et al (2015) Inferring protective CD8+ T-cell epitopes for NS5 protein of four serotypes of dengue virus Chinese isolates based on HLA-A, -B and -C Allelic distribution: implications for epitope-based universal vaccine design. PLoS ONE 10(9):e0138729
22. Duan Z-L, Liu H-F, Huang X, Wang S-N, Yang J-L, Chen X-Y et al (2015) Identification of conserved and HLA-A*2402-restricted epitopes in Dengue virus serotype 2. Virus Res 22(196):5–12
23. Duan Z, Guo J, Huang X, Liu H, Chen X, Jiang M et al (2015) Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1. J Med Virol 87(7):1077–1089
24. Comber JD, Karabudak A, Huang X, Piazza PA, Marques ETA, Philip R (2014) Dengue virus specific dual HLA binding T cell epitopes induce CD8 + T cell responses in seropositive individuals. Hum Vaccines Immunother 10(12):3531–3543
25. Mathew A, Townsley E, Ennis FA (2014) Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections. Future Microbiol 9(3):411–425
26. James EA, LaFond RE, Gates TJ, Mai DT, Malhotra U, Kwok WW (2013) Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins. J Virol 87(23):12794–12804
27. de Melo AB, Nascimento EJM, Braga-Neto U, Dhalia R, Silva AM, Oelke M et al (2013) T-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and -II binding motifs. PLoS Negl Trop Dis 7(1):e1938
28. Kuno G (2007) Chang G-JJ. Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses. Arch Virol 152(4):687–696
29. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215(3):403–410
30. Kumar S, Stecher G, Tamura K (2016) MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol
31. Kolaskar AS, Tongaonkar PC (1990) A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 276(1–2):172–174
32. Doytchinova IA, Flower DR (2007) VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinf 8:4
33. Southwood S, Sidney J, Kondo A, del Guercio MF, Appella E, Hoffman S et al (1998) Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol Baltim Md 1950 160(7):3363–3373
34. Priyadarshini V, Pradhan D, Munikumar M, Swargam S, Umamaheswari A, Rajasekhar D (2014) Genome-based approaches to develop epitope-driven subunit vaccines against pathogens of infective endocarditis. J Biomol Struct Dyn 32(6):876–889
35. Munikumar M, Priyadarshini IV, Pradhan D, Umamaheswari A, Vengamma B (2013) Computational approaches to identify common subunit vaccine candidates against bacterial meningitis. Interdiscip Sci Comput Life Sci 5(2):155–164
36. Umamaheswari A, Pradhan D, Hemanthkumar M (2012) Computer aided subunit vaccine design against pathogenic Leptospira serovars. Interdiscip Sci Comput Life Sci 4(1):38–45
37. Rakesh S, Pradhan D, Umamaheswari A (2009) In silico approach for future development of subunit vaccines against Leptospira interrogans serovar Lai. Int J Bioinforma Res 1:85–92
38. Andreatta M, Karosiene E, Rasmussen M, Stryhn A, Buus S, Nielsen M (2015) Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification. Immunogenetics 67(11–12):641–650
39. Oyarzún P, Ellis JJ, Bodén M, Kobe B (2013) PREDIVAC: CD4 + T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity. BMC Bioinf 14:52
40. Vita R, Overton JA, Greenbaum JA, Ponomarenko J, Clark JD, Cantrell JR et al (2015) The immune epitope database (IEDB) 3.0. Nucleic Acids Res 43(Database issue):D405–12
41. Andreatta M, Nielsen M (2016) Gapped sequence alignment using artificial neural networks: application to the MHC class I system. Bioinforma Oxf Engl 32(4):511–517
42. Lund O, Nascimento EJM, Maciel M, Nielsen M, Larsen MV, Lundegaard C et al (2011) Human leukocyte antigen (HLA) class I restricted epitope discovery in yellow fewer and dengue viruses: importance of HLA binding strength. PLoS ONE 6(10):e26494
43. Weiskopf D, Angelo MA, de Azeredo EL, Sidney J, Greenbaum JA, Fernando AN et al (2013) Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8 + T cells. Proc Natl Acad Sci USA 110(22):E2046–E2053
44. Sette A, Sidney J (1999) Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50(3–4):201–212
45. Larsen MV, Lundegaard C, Lamberth K, Buus S, Lund O, Nielsen M (2007) Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinf 8:424
46. Khan MA, Hossain MU, Rakib-Uz-Zaman SM, Morshed MN (2015) Epitope-based peptide vaccine design and target site depiction against Ebola viruses: an immunoinformatics study. Scand J Immunol 82(1):25–34
47. Bui H-H, Sidney J, Li W, Fusseder N, Sette A (2007) Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinf 8:361
48. Bui H-H, Sidney J, Dinh K, Southwood S, Newman MJ, Sette A (2006) Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinf 7:153
49. Adams HP, Koziol JA (1995) Prediction of binding to MHC class I molecules. J Immunol Methods 185(2):181–190
50. Maenaka K, Jones EY (1999) MHC superfamily structure and the immune system. Curr Opin Struct Biol 9(6):745–753
51. Stern LJ, Wiley DC (1994) Antigenic peptide binding by class I and class II histocompatibility proteins. Struct Lond Engl 1993 2(4):245–251
52. Wang P, Sidney J, Kim Y, Sette A, Lund O, Nielsen M et al (2010) Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinf 11:568
53. Wang P, Sidney J, Dow C, Mothé B, Sette A, Peters B (2008) A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput Biol 4(4):e1000048
54. da Silva ANMR, Nascimento EJM, Cordeiro MT, Gil LHVG, Abath FGC, Montenegro SML et al (2009) Identification of continuous human B-cell epitopes in the envelope glycoprotein of dengue virus type 3 (DENV-3). PLoS ONE 4(10):e7425
55. Wu HC, Huang YL, Chao TT, Jan JT, Huang JL, Chiang HY et al (2001) Identification of B-cell epitope of dengue virus type 1 and its application in diagnosis of patients. J Clin Microbiol 39(3):977–982
56. Jiang L, Zhou J-M, Yin Y, Fang D-Y, Tang Y-X, Jiang L-F (2010) Selection and identification of B-cell epitope on NS1 protein of dengue virus type 2. Virus Res 150(1–2):49–55
57. Khan AM, Miotto O, Nascimento EJM, Srinivasan KN, Heiny AT, Zhang GL et al (2008) Conservation and variability of dengue virus proteins: implications for vaccine design. PLoS Negl Trop Dis 2(8):e272